Search results
Results From The WOW.Com Content Network
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen) and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO(a)-LRx for ...
Ion Media, LLC (formerly known as Paxson Communications Corporation and Ion Media Networks) is a subsidiary of the E. W. Scripps Company that operates the linear broadcast networks Ion Television and Ion Plus. Prior to its acquisition by Scripps, the company owned and operated over 71 television stations in most major American markets (through ...
ION Geophysical was a technology-focused company that provided advanced acquisition equipment, software, planning, and seismic processing services, as well as seismic data libraries to the global oil and gas industry. Here are the key details: Company Overview: Name: ION Geophysical Corporation. Industry: Geophysical solutions for oil and gas.
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of -1.79% and -9.17%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The cation is always named first. Ions can be metals, non-metals or polyatomic ions. Therefore, the name of the metal or positive polyatomic ion is followed by the name of the non-metal or negative polyatomic ion. The positive ion retains its element name whereas for a single non-metal anion the ending is changed to -ide.
Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.